NRF2 activation in cancer cells is brought by not only somatic mutations in NRF2 or KEAP1 genes but also several unique mechanisms, including oncometabolites, exon skipping, and promoter methylation, in NRF2-addicted cancers. This evidence concerns the gene KEAP1 and cancer.